
Novo Nordisk announced Monday it is lowering the costs of weight loss and diabetes drugs, just weeks after striking a deal with the Trump administration to lower prices for customers. Wegovi 0.25 mg and 0.5 mg injection and Ozempic will cost $199 per month for new self-pay patients through March 31, 2026, Novo Nordisk…
Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers

